Gritstone bio, Inc.
GRTSDelisted Mar 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001656634
Gritstone bio, Inc. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on Apr 8, 2025; 56 institutions reported holding it in 13F filings for Q3 2024, worth $20.7M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Gritstone bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- +13 vs. Q3 2022
- Shares held
- 44.1M
- +10.7M (+32.0%) vs. Q3 2022
- Total value
- $152.1M
- +$66.2M (+77.1%) vs. Q3 2022
- New holders
- 24
- 29 more added
- Sold out
- 11
- 24 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GRTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 6 | $773 |
| Q3 2024 | 56 | $20.7M |
| Q2 2024 | 79 | $24.2M |
| Q1 2024 | 85 | $120.4M |
| Q4 2023 | 88 | $85.9M |
| Q3 2023 | 89 | $83.6M |
| Q2 2023 | 88 | $99.5M |
| Q1 2023 | 91 | $128.6M |
| Q4 2022 | 91 | $152.1M |
| Q3 2022 | 79 | $86.0M |
| Q2 2022 | 87 | $85.1M |
| Q1 2022 | 117 | $164.9M |
| Q4 2021 | 115 | $630.0M |
| Q3 2021 | 92 | $458.4M |
| Q2 2021 | 102 | $318.2M |
| Q1 2021 | 99 | $321.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Gritstone bio, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LMR Partners LLP | 0 | $0 | 0.00% | −15,240−100.0% | Sold out |
| Spears Abacus Advisors LLC | 0 | $0 | 0.00% | −11,809−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |